Seroquel XR sNDA For Depression, Anxiety On Track For 1H 2008 Following Positive Phase III Data

AstraZeneca tells DAILY that despite the crowded market for depression and anxiety therapies, quetiapine would appeal to patients whose current treatments inadequately control symptoms.